Literature DB >> 15784559

The innate immune system is activated by stimulation of vaginal epithelial cells with Staphylococcus aureus and toxic shock syndrome toxin 1.

Marnie L Peterson1, Kevin Ault, Mary J Kremer, Aloysius J Klingelhutz, Catherine C Davis, Christopher A Squier, Patrick M Schlievert.   

Abstract

Despite knowledge of the effects of toxic shock syndrome (TSS) toxin 1 (TSST-1) on the adaptive immune system, little is known about stimulation of the innate immune system, particularly epithelial cells. This study investigated the interactions of TSS Staphylococcus aureus and TSST-1 with human vaginal epithelial cells (HVECs) and porcine mucosal surfaces. When cocultured with HVECs for 6 h, TSS S. aureus MN8 proliferated, formed aggregates on the HVEC surfaces, and produced exotoxins. Receptor binding studies showed that 35S-TSST-1 bound to 5 x 10(4) receptors per HVEC, with saturation at 15 min. Affymetrix Human GeneChip U133A microarray analysis determined S. aureus MNSM (100 bacteria/HVEC) caused at least twofold up- or down-regulation of 410 HVEC genes by 6 h; these data were also confirmed with S. aureus MN8. TSST-1 (100 microg/ml) caused up- or down-regulation of 2,386 HVEC genes by 6 h. In response to S. aureus, the HVEC genes most up-regulated compared to those in controls were those coding for chemokines or cytokines--MIP-3alpha, 478-fold; GRO-alpha, 26-fold; GRO-beta, 14-fold; and GRO-gamma, 30-fold--suggesting activation of innate immunity. TSST-1 also caused up-regulation of chemokine/cytokine genes. Chemokine/cytokine gene up-regulation was confirmed by enzyme-linked immunosorbent assays measuring the corresponding proteins induced by S. aureus and TSST-1. S. aureus MN8, when incubated with porcine vaginal tissue, increased the flux of 35S-TSST-1 across the mucosal surface. This was accompanied by influx of lymphocytes into the upper layers of the tissue. These data suggest innate immune system activation through epithelial cells, reflected in chemokine/cytokine production and influx of lymphocytes, may cause changes in vaginal mucosa permeability, facilitating TSST-1 penetration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15784559      PMCID: PMC1087460          DOI: 10.1128/IAI.73.4.2164-2174.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  63 in total

Review 1.  A genomic view of helper T cell subsets.

Authors:  Lars Rogge
Journal:  Ann N Y Acad Sci       Date:  2002-12       Impact factor: 5.691

2.  Functional analysis of the TCR binding domain of toxic shock syndrome toxin-1 predicts further diversity in MHC class II/superantigen/TCR ternary complexes.

Authors:  John K McCormick; Timothy J Tripp; Andrea S Llera; Eric J Sundberg; Martin M Dinges; Roy A Mariuzza; Patrick M Schlievert
Journal:  J Immunol       Date:  2003-08-01       Impact factor: 5.422

Review 3.  How we detect microbes and respond to them: the Toll-like receptors and their transducers.

Authors:  B Beutler; K Hoebe; X Du; R J Ulevitch
Journal:  J Leukoc Biol       Date:  2003-07-01       Impact factor: 4.962

Review 4.  Antigen degradation or presentation by MHC class I molecules via classical and non-classical pathways.

Authors:  Monique Grommé; Jacques Neefjes
Journal:  Mol Immunol       Date:  2002-10       Impact factor: 4.407

5.  Tri-state toxic-state syndrome study. I. Epidemiologic findings.

Authors:  M T Osterholm; J P Davis; R W Gibson; J S Mandel; L A Wintermeyer; C M Helms; J C Forfang; J Rondeau; J M Vergeront
Journal:  J Infect Dis       Date:  1982-04       Impact factor: 5.226

6.  Toxin and enzyme characterization of Staphylococcus aureus isolates from patients with and without toxic shock syndrome.

Authors:  P M Schlievert; M T Osterholm; J A Kelly; R D Nishimura
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

7.  Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome.

Authors:  P M Schlievert; K N Shands; B B Dan; G P Schmid; R D Nishimura
Journal:  J Infect Dis       Date:  1981-04       Impact factor: 5.226

8.  Nonmenstrual toxic shock syndrome: a review of 130 cases.

Authors:  A L Reingold; N T Hargrett; B B Dan; K N Shands; B Y Strickland; C V Broome
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

9.  Toxic shock syndrome: clinical, laboratory, and pathologic findings in nine fatal cases.

Authors:  S M Larkin; D N Williams; M T Osterholm; R W Tofte; Z Posalaky
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

10.  Clinical safety-in-use study of a new tampon design.

Authors:  Stacey E Shehin; Michaelle B Jones; Anne E Hochwalt; Frank C Sarbaugh; Stephen Nunn
Journal:  Infect Dis Obstet Gynecol       Date:  2003
View more
  57 in total

1.  Checks and balances: the ocular response to infection.

Authors:  Michelle C Callegan
Journal:  Virulence       Date:  2010 Jul-Aug       Impact factor: 5.882

2.  Staphylococcus aureus exotoxins are present in vivo in tampons.

Authors:  Patrick M Schlievert; Kimberly A Nemeth; Catherine C Davis; Marnie L Peterson; Bruce E Jones
Journal:  Clin Vaccine Immunol       Date:  2010-03-24

3.  Superantigens of Staphylococcus aureus from patients with diabetic foot ulcers.

Authors:  Bao G Vu; Christopher S Stach; Wilmara Salgado-Pabón; Daniel J Diekema; Sue E Gardner; Patrick M Schlievert
Journal:  J Infect Dis       Date:  2014-06-20       Impact factor: 5.226

4.  A disintegrin and metalloproteinase 17 (ADAM17) and epidermal growth factor receptor (EGFR) signaling drive the epithelial response to Staphylococcus aureus toxic shock syndrome toxin-1 (TSST-1).

Authors:  Laura M Breshears; Patrick M Schlievert; Marnie L Peterson
Journal:  J Biol Chem       Date:  2012-07-25       Impact factor: 5.157

5.  Proinflammatory exoprotein characterization of toxic shock syndrome Staphylococcus aureus.

Authors:  Ying-Chi Lin; Michele J Anderson; Petra L Kohler; Kristi L Strandberg; Michael E Olson; Alexander R Horswill; Patrick M Schlievert; Marnie L Peterson
Journal:  Biochemistry       Date:  2011-07-21       Impact factor: 3.162

6.  New insights into the prevention of staphylococcal infections and toxic shock syndrome.

Authors:  Ying-Chi Lin; Marnie L Peterson
Journal:  Expert Rev Clin Pharmacol       Date:  2010-11-01       Impact factor: 5.045

7.  Vaginal toxic shock reaction triggering desquamative inflammatory vaginitis.

Authors:  Nigel Pereira; Thomas D Edlind; Patrick M Schlievert; Paul Nyirjesy
Journal:  J Low Genit Tract Dis       Date:  2013-01       Impact factor: 1.925

Review 8.  Device-Associated Menstrual Toxic Shock Syndrome.

Authors:  Patrick M Schlievert; Catherine C Davis
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

9.  Glycerol monolaurate prevents mucosal SIV transmission.

Authors:  Qingsheng Li; Jacob D Estes; Patrick M Schlievert; Lijie Duan; Amanda J Brosnahan; Peter J Southern; Cavan S Reilly; Marnie L Peterson; Nancy Schultz-Darken; Kevin G Brunner; Karla R Nephew; Stefan Pambuccian; Jeffrey D Lifson; John V Carlis; Ashley T Haase
Journal:  Nature       Date:  2009-03-04       Impact factor: 49.962

10.  Epithelial Cell Gene Expression Induced by Intracellular Staphylococcus aureus.

Authors:  Xianglu Li; William G Fusco; Keun S Seo; Kenneth W Bayles; Erin E Mosley; Mark A McGuire; Gregory A Bohach
Journal:  Int J Microbiol       Date:  2009-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.